Contact:

Teresa Powers

636.733.1392

tpowers@relivinc.com


RelivSoy Labs Launch LunaRich, a Healthier Soy
Biotech breakthrough produces soy powder with over five times key bioactive component

CHESTERFIELD, Mo., Jan. 17, 2012 /PRNewswire/ -- Reliv International, Inc. (NASDAQ:),Soy Labs LLC today announced the creation of LunaRich™, an exclusive soy powder developed at the Missouri Plant Science Center (MPSC). Reliv is adding LunaRich to one of its nutritional supplementswill reveal that product at the Reliv National Conference in Reno, Nv., Feb. 17.

"Biotechnology is vital to Missouri's economic future," said former U.S. Sen. Kit Bond. "Our vision for the Missouri Plant Science Center is to unite our state's scientists, farmersprivate-sector job creators to spawn biotech innovation. The collaborative effort between RelivSoy Labs is helping us realize that vision by bringing cutting-edge biotech products to market."

LunaRich is a whole soy powder containing five to ten times more lunasin than the industry standard. Lunasin is a peptide found naturally in soy that scientists have identified as the key to many of soy's documented health benefits. These include cholesterol management, heart healthweight loss, among others. LunaRich is the first product to come out of the joint biotechnology researchdevelopment partnership that Reliv, Soy Labsthe MPSC formed in August 2011.

"A growing body of research shows that the lunasin peptide is one of the most important bioactive components of soy," said Dr. Alfredo Galvez, the MPSC's lead scientific advisor. "In creating LunaRich for Reliv, we have maximized lunasin levels in a soy powder."

Dr. Galvez first discovered lunasin in 1996 during research at UC Berkley to improve the nutritional profile of soy protein. More than 40 peer-reviewedpublished studies have documented lunasin's health benefits. Research by 21 institutions supported by 27 publicprivate funding sources has resulted in nine patents.

The amount of lunasin in soybeans varies significantly based on seed, soilenvironment. The MPSC refines specially selected soybeans grown exclusively for Reliv to maximize levels of lunasin in LunaRich.

"This is a significant step forward for Relivfor nutrition science. LunaRich is an extraordinary ingredient with solid clinical data behind it," said Dr. Carl W. Hastings, Reliv's chief scientific officer. "As scientists learn more about the mechanisms that make soy a nutritional superfood, Reliv is proud to lead the way in making the fruits of these discoveries available to all."

About Reliv International, Inc.

Reliv International, Inc., based in Chesterfield, Mo., produces nutritional supplements that promote optimal nutrition along with premium , , , , , . The company sells its products through an international network marketing system of independent distributors in 15 countries. Learn more about Reliv at , or .

About Soy Labs LLC

Soy Labs is the premier soy-based ingredient supplier to the nutrition industry. The company spearheads researchdevelops proprietary, soy peptides, ingredients,formulaic compounds for inclusion in nutritional supplements, cosmeceuticals, soyfoods, functional foodsbeverages. Soy Labs has received research funding from the National Institutes of Health, the U.S. Department of Defense, the American Institute for Cancer Research, the BiotechnologyBiological Sciences Research Councilother organizations. For more information about the companyits products, visit the web site at .

About the Missouri Plant Science Center

The Missouri Plant Science Center is a joint venture of the Missouri Technology Corp., the University of Missouri Systemthe city of Mexico, Mo. The MPSC is a shared-use facility where researchers work alongside businessindustry experts in a multi-disciplinary environment. The center facilitates the collaboration between scientificentrepreneurial minds to turn the latest biotechnology research innovations into functional real-world applicationsconsumer goods.

Forward-looking statements

Statements made in this news release that are not historical facts are "forward-looking" statements (as defined in the Private Securities Litigation Reform Act of 1995) that involve risksuncertaintiesare subject to change at any time. These forward-looking statements may include, but are not limited to, statements containing words such as "may," "should," "could," "would," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential," "continue" or similar expressions. Factors that could cause actual results to differ are identified in the public filings made by Reliv with the SecuritiesExchange Commission. More information on factors that could affect Reliv's businessfinancial results are included in its public filings made with the SecuritiesExchange Commission, including its Annual Report on Form 10-KQuarterly Reports on Form 10-Q, copies of which are available on the Company's web site, .

SOURCE Reliv International, Inc.


distribué par

Ce noodl a été diffusé par Reliv International Inc. et initialement mise en ligne sur le site http://www.reliv.com. La version originale est disponible ici.

Ce noodl a été distribué par noodls dans son format d'origine et sans modification sur 2012-01-17 18:38:42 PM et restera accessible depuis ce lien permanent.

Cette annonce est protégée par les règles du droit d'auteur et toute autre loi applicable, et son propriétaire est seul responsable de sa véracité et de son originalité.